| Estimating the mean and variance from the median, range, and the size of a sample SP Hozo, B Djulbegovic, I Hozo BMC medical research methodology 5, 1-10, 2005 | 7963 | 2005 |
| GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias) GH Guyatt, AD Oxman, G Vist, R Kunz, J Brozek, P Alonso-Coello, ... Journal of clinical epidemiology 64 (4), 407-415, 2011 | 2757 | 2011 |
| Pharmaceutical industry sponsorship and research outcome and quality: systematic review J Lexchin, LA Bero, B Djulbegovic, O Clark bmj 326 (7400), 1167-1170, 2003 | 2687 | 2003 |
| Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group International Myeloma Working Group British journal of haematology 121 (5), 749-757, 2003 | 2641 | 2003 |
| GRADE guidelines: 5. Rating the quality of evidence—publication bias GH Guyatt, AD Oxman, V Montori, G Vist, R Kunz, J Brozek, ... Journal of clinical epidemiology 64 (12), 1277-1282, 2011 | 1769 | 2011 |
| How to increase value and reduce waste when research priorities are set I Chalmers, MB Bracken, B Djulbegovic, S Garattini, J Grant, ... The Lancet 383 (9912), 156-165, 2014 | 1438 | 2014 |
| Red blood cell transfusion: a clinical practice guideline from the AABB JL Carson, BJ Grossman, S Kleinman, AT Tinmouth, MB Marques, ... Annals of internal medicine 157 (1), 49-58, 2012 | 1404 | 2012 |
| GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength JC Andrews, HJ Schünemann, AD Oxman, K Pottie, JJ Meerpohl, ... Journal of clinical epidemiology 66 (7), 726-735, 2013 | 1395 | 2013 |
| Recommendations on the use of 18F-FDG PET in oncology JW Fletcher, B Djulbegovic, HP Soares, BA Siegel, VJ Lowe, GH Lyman, ... Journal of Nuclear Medicine 49 (3), 480-508, 2008 | 1325 | 2008 |
| Screening for prostate cancer D Ilic, MM Neuberger, M Djulbegovic, P Dahm Cochrane database of systematic reviews, 2013 | 1149 | 2013 |
| Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials J Koreth, R Schlenk, KJ Kopecky, S Honda, J Sierra, BJ Djulbegovic, ... Jama 301 (22), 2349-2361, 2009 | 1111 | 2009 |
| Progress in evidence-based medicine: a quarter century on B Djulbegovic, GH Guyatt The lancet 390 (10092), 415-423, 2017 | 1007 | 2017 |
| Platelet transfusion: a clinical practice guideline from the AABB RM Kaufman, B Djulbegovic, T Gernsheimer, S Kleinman, AT Tinmouth, ... Annals of internal medicine 162 (3), 205-213, 2015 | 1005 | 2015 |
| Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia CL Bennett, SM Silver, B Djulbegovic, AT Samaras, CA Blau, KJ Gleason, ... Jama 299 (8), 914-924, 2008 | 975 | 2008 |
| Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma RI Fisher, SH Bernstein, BS Kahl, B Djulbegovic, MJ Robertson, S De Vos, ... Journal of clinical oncology 24 (30), 4867-4874, 2006 | 882 | 2006 |
| Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology JD Rizzo, AE Lichtin, SH Woolf, J Seidenfeld, CL Bennett, D Cella, ... Blood, The Journal of the American Society of Hematology 100 (7), 2303-2320, 2002 | 856 | 2002 |
| Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients J Bohlius, J Wilson, J Seidenfeld, M Piper, G Schwarzer, J Sandercock, ... Journal of the National Cancer Institute 98 (10), 708-714, 2006 | 833 | 2006 |
| GRADE guidelines: 12. Preparing summary of findings tables—binary outcomes GH Guyatt, AD Oxman, N Santesso, M Helfand, G Vist, R Kunz, J Brozek, ... Journal of clinical epidemiology 66 (2), 158-172, 2013 | 797 | 2013 |
| D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis G Lippi, EJ Favaloro Thrombosis and haemostasis 120 (05), 876-878, 2020 | 754 | 2020 |
| Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials J Bohlius, K Schmidlin, C Brillant, G Schwarzer, S Trelle, J Seidenfeld, ... The Lancet 373 (9674), 1532-1542, 2009 | 725 | 2009 |
